Position in GH
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$1,250,199
+$598,252 QoQ
Shares Held
8,333
+18.1% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#297
of 594 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Swiss Life Asset Management Ltd holds $151,561,358 across 20 Diagnostics & Research names. GH ranks #13 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
60,525 | $30,344,813 | |
| 2 | DHR |
Danaher Corp /De/
|
140,482 | $26,759,011 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
38,401 | $20,215,821 | |
| 4 | DGX |
Quest Diagnostics Inc
|
66,553 | $14,105,907 | |
| 5 | WAT |
Waters Corp /De/
|
32,328 | $12,124,293 | |
| 6 | A |
Agilent Technologies, Inc.
|
84,692 | $11,249,637 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
41,052 | $7,932,066 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
5,758 | $7,355,902 |
All Filings in GH
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,250,199 | 8,333 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $651,947 | 7,058 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $540,320 | 5,290 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $326,582 | 5,227 | Shares | Sole | 2025-12-02 | |
| No filing history on record for this holder in this stock. | ||||||